Xentria Highlights New Episode of Lifetime® TV’s “Behind the Mystery” Segment of “The Balancing Act®” on Sarcoidosis
December 14, 2021
CHICAGO–(BUSINESS WIRE)–Xentria Inc., a biotech company focused on developing novel biologics to address unmet clinical needs, today highlighted a new sarcoidosis episode of The Balancing Act airing on Lifetime on a specialized, recurring segment devoted to rare and genetic diseases. The live segment, which aired at 7:30 a.m. ET this morning, follows the unique diagnosis and treatment journey of a sarcoidosis patient and provides clinical insights from Dr. Peter Sporn, Director of the Sarcoidosis Center of Excellence at Northwestern Medicine in Chicago, regarding this rare and difficult to treat disease. The episode will be rebroadcast on December 14th, 2021 at 7:30 a.m. (ET/PT) on Lifetime TV.
PROMOTED
Celebrate Mother’s Day with The Balancing Act’s exclusive guide, dedicated to creating a day just as special as the moms in our lives. Dive into a treasure trove of activities, delectable recipes, and thoughtful gift ideas curated to make this Mother’s Day an unforgettable celebration of love and appreciation.
PROMOTED
Today's show includes advanced oral care, poverty educational resources, delicious Thai food, funeral planning, and so much more
PROMOTED
Parikh Law Group was founded in 2010 to provide solid, experienced, and affordable representation.
Comments